Drug Profile
Research programme: RGD-targeted TRAIL conjugates - Kreatech Biotechnology
Alternative Names: RGD-avidin-TRAIL conjugate; RGD-TRAIL conjugateLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator KREATECH Biotechnology
- Class
- Mechanism of Action TNF related apoptosis inducing ligand stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Netherlands
- 07 Dec 2005 Preclinical trials in Cancer in Netherlands (unspecified route)
- 07 Dec 2005 Data presented at the 17th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2005) have been added to the Cancer pharmacodynamics section